Group One Trading’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-91,900
| Closed | -$521K | – | 9045 |
|
|
2025
Q3 | $521K | Buy |
91,900
+200
| +0.2% | +$1.02K | ﹤0.01% | 3660 |
|
|
2025
Q2 | $349K | Buy |
91,700
+91,000
| +13,000% | +$283K | ﹤0.01% | 3770 |
|
|
2025
Q1 | $1.84K | Buy |
700
+400
| +133% | +$1.3K | ﹤0.01% | 7022 |
|
|
2024
Q4 | $1.06K | Sell |
300
-18,800
| -98% | -$72K | ﹤0.01% | 6874 |
|
|
2024
Q3 | $87.1K | Buy |
19,100
+200
| +1% | +$967 | ﹤0.01% | 4288 |
|
|
2024
Q2 | $82.2K | Buy |
18,900
+700
| +4% | +$3.08K | ﹤0.01% | 4118 |
|
|
2024
Q1 | $91.4K | Sell |
18,200
-15,800
| -46% | -$88.5K | ﹤0.01% | 4228 |
|
|
2023
Q4 | $213K | Sell |
34,000
-18,700
| -35% | -$107K | ﹤0.01% | 3811 |
|
|
2023
Q3 | $375K | Buy |
52,700
+4,800
| +10% | +$37.8K | ﹤0.01% | 3204 |
|
|
2023
Q2 | $488K | Buy |
47,900
+8,600
| +22% | +$89.8K | ﹤0.01% | 3053 |
|
|
2023
Q1 | $356K | Buy |
39,300
+25,300
| +181% | +$185K | ﹤0.01% | 3094 |
|
|
2022
Q4 | $100K | Buy |
+14,000
| New | +$85.5K | ﹤0.01% | 4434 |
|
Group One Trading's SCPH Position: Q4 2025 in Review
Group One Trading sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 15,630 shares — an estimated $88.6K sold.
Group One Trading first reported a position in SCPH in Q1 2022 and held it in 12 quarters. The position peaked at $291K in Q3 2024. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Group One Trading reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 15,630 scPharmaceuticals shares in Q4 2025, an estimated $88.6K.
- Group One Trading first reported a position in scPharmaceuticals in Q1 2022 and held it in 12 quarters.
- Group One Trading's scPharmaceuticals position peaked at $291K in Q3 2024.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.